Effect of levosimendan on E/E' ratio in patients with ischemic heart failure

Duygu H., Ozerkan F., NALBANTGİL S., ZOGHİ M., AKILLI A., AKIN M., ...Daha Fazla

INTERNATIONAL JOURNAL OF CARDIOLOGY, cilt.123, sa.2, ss.201-203, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Kısa Makale
  • Cilt numarası: 123 Sayı: 2
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1016/j.ijcard.2006.11.145
  • Dergi Adı: INTERNATIONAL JOURNAL OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.201-203
  • Anahtar Kelimeler: levosimendan, dobutamine, ischemic heart failure, E/E' ratio
  • Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

Background: Levosimendan is a novel positive inotropic calcium sensitizer agent used in acute heart failure. In acute heart failure, it improves hemodynamic parameters more favorably than the conventional positive inotropes. In this study, the effect levosimendan on E/E' ratio as a non-invasive indicator of LV filling pressure was evaluated compared to dobutamine in a prospective, randomized, patient-blind manner.